Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Conference Proceedings
  • Disease Areas
  • Other Medical News
  • Media
    • Podcast
    • Video
    • Education
  • About
    • Conference Proceedings
    • Vacancies

Tag: VTE

Psoriasis treatment: no elevation of MACE and VTE on deucravacitinib

Presented By
Prof. Mark Lebwohl , Icahn School of Medicine at Mount Sinai, NY, USA
Trial
Phase 3, POETYK PSO-1, POETYK PSO-2
Conference
SPIN 2022

26 August, 2022 09:50

VTE in global registry data more common in JAK inhibitor-treated RA patients

Presented By
Prof. Adeline Ruyssen-Witrand, Toulouse University Hospital, France
Conference
EULAR 2022

21 July, 2022 14:52

Milvexian phase 2 data supports safety and efficacy for VTE prevention after total knee replacement

Presented By
Prof. Jeffrey Weitz, McMaster University, Canada
Trial
Phase 2, AXIOMATIC-TKR
Conference
AHA 2021

14 January, 2022 13:54

PAD: Rivaroxaban reduces VTE risk after revascularisation

Presented By
Dr Connie Hess; Prof. Judith Hsia
Trial
VOYAGER PAD
Conference
AHA 2020

18 February, 2021 11:45

Surgical bleeding risk most important determinant of bleeding outcomes

Presented By
Dr Kira MacDougall, Staten Island University Hospital, USA
Trial
PAUSE
Conference
ISTH 2020

8 September, 2020 16:27

Similar bleeding rates in patients with VTE and AF treated with DOACs

Presented By
Dr Farès Moustafa, CHU Clermont Ferrand, France
Conference
ISTH 2020

8 September, 2020 16:21

Residual pulmonary obstruction may predict risk of VTE recurrence

Presented By
Dr Robin Chaux, University Hospital St. Etienne, France
Conference
ISTH 2020

8 September, 2020 15:50

Risk of checkpoint inhibitor-associated thromboembolic events important for cancer prognosis

Presented By
Dr Florian Moik, Medical university of Vienna, Austria
Trial
Cohort study
Conference
ISTH 2020

8 September, 2020 15:44

Crosstalk between inflammation and coagulation in severe COVID-19 infections

Presented By
Prof. Roberta Gualtierotti, University of Milan, Italy
Conference
ISTH 2020

8 September, 2020 15:21

COVID-19 associated with higher VTE rates relative to influenza

Presented By
Dr Milou Stals, Leiden University Medical Centre, the Netherlands
Conference
ISTH 2020

8 September, 2020 15:18

Therapeutic anticoagulation not associated with lower mortality rates in COVID-19 ICU patients

Presented By
Dr Hanny Al-Samkari, Massachusetts General Hospital, USA
Trial
Cohort study
Conference
ISTH 2020

8 September, 2020 15:15

COVID-19 not associated with heightened VTE risk after discharge

Presented By
Dr Matthias Engelen, University Hospital Leuven, Belgium
Conference
ISTH 2020

8 September, 2020 15:09

Lower embryopathy risk with DOAC versus VKA during pregnancy

Presented By
Dr Jan Beyer-Westendorf, UNI-Klinikum Carl Gustav Carus Medizinische Klinik I, Germany
Conference
ISTH 2020

8 September, 2020 14:53

Higher thrombotic risk in NSCLC patient with ALK rearrangement

Presented By
Dr Hanny Al-Samkari, Massachusetts General Hospital, USA
Conference
ISTH 2020

8 September, 2020 14:41

Apixaban offers new perspective for cancer patients in need of anticoagulation

Presented By
Prof. G. Agnelli, University of Perugia, Italy
Trial
Phase 3, CARAVAGGIO
Conference
ACC 2020

7 September, 2020 23:13

Rivaroxaban superior to enoxaparin in preventing VTE in non-major orthopaedic surgery

Presented By
Prof. N. Rosencher, Paris Center University Hospital, France
Trial
PRONOMOS
Conference
ACC 2020

7 September, 2020 23:07

COVID-19 and inflammatory rheumatic disease: some key issues

Presented By
Prof. G. Burmester, Charité University Hospital, Germany
Conference
EULAR 2020

14 August, 2020 15:06
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy